Michael Catlin - 20 Jul 2023 Form 3 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Director
Signature
/s/ Michael Catlin
Issuer symbol
KRBPQ
Transactions as of
20 Jul 2023
Net transactions value
$0
Form type
3
Filing time
10 Aug 2023, 12:28:13 UTC
Next filing
06 Oct 2023

No securities are beneficially owned.